KalVista Pharmaceuticals
KALV
KALV
48 hedge funds and large institutions have $278M invested in KalVista Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
14.63% more ownership
Funds ownership: 58.49% → 73.12% (+15%)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
Holders
48
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$23.4M | |
| 2 | +$16.8M | |
| 3 | +$14.4M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$13.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.75M |
Top Sellers
| 1 | -$865K | |
| 2 | -$545K | |
| 3 | -$379K | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
-$167K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$52.1K |